{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:53:56Z","timestamp":1790906036232,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited treatment options due to the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) receptors. This study investigates the anticancer potential and underlying molecular mechanisms of the traditional ayurvedic formulation\n                    <jats:italic>Kanchanara guggulu<\/jats:italic>\n                    in TNBC cells. The cytotoxic, anti-migratory, and membrane integrity-modulating effects of\n                    <jats:italic>Kanchanara guggulu<\/jats:italic>\n                    on MDA-MB-231 cells were assessed using MTT, wound-healing, and Live\/Dead assays. Untargeted LC\u2013MS\/MS metabolomics identified over 1,019\u00a0metabolites, of which 237 met drug-likeness and Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) criteria. Network pharmacology revealed 50 shared targets with TNBC-associated proteins, highlighting enrichment in PI3K\/AKT\/mTOR, HIF-1, AGE\u2013RAGE, calcium signaling, and microRNA-related pathways. Molecular docking (LibDock and CDOCKER) identified top bioactive candidates with strong binding affinity towards AKT1, supported by density functional theory (DFT) showing favorable electronic stability. Experimental validation demonstrated significant dose-dependent cytotoxicity (IC\u2085\u2080 = 45 \u00b5g\/mL), inhibition of migration, and increased cell death. Western blot analysis confirmed downregulation of phospho-AKT and mTOR, indicating suppression of PI3K\/AKT\/mTOR signaling. Overall, TNBC cells showed reduced proliferative and migratory potential upon treatment, suggesting that\n                    <jats:italic>Kanchanara guggulu<\/jats:italic>\n                    extract exerts anticancer effects and provides promising lead compounds for TNBC therapy development.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-60293-4","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:35:06Z","timestamp":1783089306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Untargeted metabolomics and network pharmacology unveil AKT1 inhibition by Kanchanara Guggulu in triple-negative breast cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Kadabagere Narayanaswamy","family":"Hemavathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravishankar","family":"Pervaje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thottethodi Subramanya Keshava","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0899-2839","authenticated-orcid":false,"given":"Shobha","family":"Dagamajalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"60293_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071102","volume":"17","author":"E Carvalho","year":"2024","unstructured":"Carvalho, E., Canberk, S., Schmitt, F. & Vale, N. Molecular subtypes and mechanisms of breast cancer: precision medicine approaches for targeted therapies. Cancers 17, 1102 (2024).","journal-title":"Cancers"},{"key":"60293_CR2","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1021\/acsomega.2c07480","volume":"8","author":"Y Wu","year":"2023","unstructured":"Wu, Y. et al. Z-Guggulsterone induces cell cycle arrest and apoptosis by targeting the p53\/CCNB1\/PLK1 pathway in triple-negative breast cancer. ACS Omega 8, 2780\u20132792 (2023).","journal-title":"ACS Omega"},{"key":"60293_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2024.100694","volume":"5","author":"T Qin","year":"2025","unstructured":"Qin, T. et al. Pharmacological mechanisms of berberine against triple negative breast cancer: Integration of network pharmacology and experimental validation. Phytomed. Plus 5, 100694 (2025).","journal-title":"Phytomed. Plus"},{"key":"60293_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00928-2","volume":"30","author":"Z Wu","year":"2024","unstructured":"Wu, Z. et al. Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer. Mol. Med. 30, 166 (2024).","journal-title":"Mol. Med."},{"key":"60293_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14171875","volume":"14","author":"VB Varzaru","year":"2024","unstructured":"Varzaru, V. B. et al. Triple-negative breast cancer: molecular particularities still a challenge. Diagnostics 14, 1875 (2024).","journal-title":"Diagnostics"},{"key":"60293_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.836417","volume":"9","author":"NM Almansour","year":"2022","unstructured":"Almansour, N. M. Triple-negative breast cancer: a brief review about epidemiology, risk factors, signaling pathways, treatment and role of artificial intelligence. Front. Mol. Biosci. 9, 836417 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"60293_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-071674","volume":"381","author":"RA Leon-Ferre","year":"2023","unstructured":"Leon-Ferre, R. A. & Goetz, M. P. Advances in systemic therapies for triple negative breast cancer. BMJ 381, e071674 (2023).","journal-title":"BMJ"},{"key":"60293_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","volume":"15","author":"S Zhu","year":"2023","unstructured":"Zhu, S. et al. Recent advances in therapeutic strategies for triple-negative breast cancer. J. Hematol. Oncol. 15, 121 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"60293_CR9","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3390\/biom13081207","volume":"13","author":"AG Chapdelaine","year":"2023","unstructured":"Chapdelaine, A. G. & Sun, G. Challenges and opportunities in developing targeted therapies for triple negative breast cancer. Biomolecules 13, 1207 (2023).","journal-title":"Biomolecules"},{"key":"60293_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1042\/BST20191055","volume":"48","author":"S Lev","year":"2020","unstructured":"Lev, S. Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis. Biochem. Soc. Trans. 48, 657\u2013665 (2020).","journal-title":"Biochem. Soc. Trans."},{"key":"60293_CR11","doi-asserted-by":"publisher","first-page":"32231","DOI":"10.1021\/acsomega.3c04345","volume":"8","author":"S Venkatesan","year":"2023","unstructured":"Venkatesan, S., Chanda, K. & Balamurali, M. M. Recent advancements of aptamers in cancer therapy. ACS Omega 8, 32231\u201332243 (2023).","journal-title":"ACS Omega"},{"key":"60293_CR12","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.2174\/1389201023666211230113658","volume":"23","author":"A Kanugo","year":"2022","unstructured":"Kanugo, A., Gautam, R. K. & Kamal, M. A. Recent advances of nanotechnology in the diagnosis and therapy of triple-negative breast cancer (TNBC). Curr. Pharm. Biotechnol. 23, 1581\u20131595 (2022).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"60293_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e13684","volume":"9","author":"M Ali","year":"2023","unstructured":"Ali, M. et al. Recent advance of herbal medicines in cancer\u2014a molecular approach. Heliyon 9, e13684 (2023).","journal-title":"Heliyon"},{"key":"60293_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.714628","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Network pharmacology\u2013based identification of key mechanisms of Xihuang pill in the treatment of triple-negative breast cancer stem cells. Front. Pharmacol. 12, 714628 (2021).","journal-title":"Front. Pharmacol."},{"issue":"4","key":"60293_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26041109","volume":"26","author":"CA Dehelean","year":"2021","unstructured":"Dehelean, C. A. et al. Plant-derived anticancer compounds as new perspectives in drug discovery and alternative therapy. Molecules 26(4), 1109 (2021).","journal-title":"Molecules"},{"key":"60293_CR16","unstructured":"G., P. & Kurle Laxmi, B. A critical review of Kanchanara guggulu\u2014a poly herbal formulation. Int. J. Trend Sci. Res. Dev. 6 1275\u20131280 (2022)."},{"key":"60293_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0974-8520.153750","volume":"35","author":"K Dhiman","year":"2014","unstructured":"Dhiman, K. Ayurvedic intervention in the management of uterine fibroids: a case series. Ayu 35, 303\u2013308 (2014).","journal-title":"Ayu"},{"key":"60293_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.joim.2018.10.001","volume":"16","author":"P Tomar","year":"2018","unstructured":"Tomar, P. et al. Cytotoxic and antiproliferative activity of kanchnar guggulu, an Ayurvedic formulation. J. Integr. Med. 16, 411\u2013417 (2018).","journal-title":"J. Integr. Med."},{"issue":"4","key":"60293_CR19","doi-asserted-by":"publisher","first-page":"546","DOI":"10.2174\/1573407215666181224105826","volume":"16","author":"M Abdelkarim","year":"2018","unstructured":"Abdelkarim, M. et al. 3,6-dichloro-1,2,4,5-tetrazine assayed at high doses in the metastatic breast cancer cell line MDA-MB-231 reduces cell numbers and induces apoptosis. Curr. Bioact. Compd. 16(4), 546\u2013550 (2018).","journal-title":"Curr. Bioact. Compd."},{"issue":"5","key":"60293_CR20","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/tox.23090","volume":"36","author":"I Limam","year":"2021","unstructured":"Limam, I. et al. Hydromethanolic root and aerial part extracts from Echium arenarium Guss suppress proliferation and induce apoptosis of multiple myeloma cells through mitochondrial pathway. Environ. Toxicol. 36(5), 874\u2013886 (2021).","journal-title":"Environ. Toxicol."},{"issue":"7","key":"60293_CR21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH image to ImageJ: 25 years of image analysis. Nat. Methods 9(7), 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"60293_CR22","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1002\/ptr.7449","volume":"36","author":"G Karthikkeyan","year":"2022","unstructured":"Karthikkeyan, G. et al. Metabolomics analysis highlights Yashtimadhu-mediated neuroprotection in a rotenone-induced cellular model of Parkinson\u2019s disease by restoring the mTORC1-AMPK1 axis in autophagic regulation. Phytother. Res. 36, 2207\u20132222 (2022).","journal-title":"Phytother. Res."},{"key":"60293_CR23","volume":"17","author":"KN Hemavathi","year":"2026","unstructured":"Hemavathi, K. N., Middha, S. K., Pervaje, R., Prasad, T. S. K. & Dagamajalu, S. Integrative experimental and network pharmacology analysis reveals Madhunashini as a PAI-1\u2013targeting therapeutic candidate for triple-negative breast cancer associated with diabetes. Eur. J. Med. Chem. Rep. 17, 100348 (2026).","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"60293_CR24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/nbt.2377","volume":"30","author":"MC Chambers","year":"2012","unstructured":"Chambers, M. C. et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat. Biotechnol. 30, 918\u2013920 (2012).","journal-title":"Nat. Biotechnol."},{"key":"60293_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/1471-2105-11-395","volume":"11","author":"T Pluskal","year":"2010","unstructured":"Pluskal, T., Castillo, S., Villar-Briones, A. & Ore\u0161i\u010d, M. MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinform. 11, 395 (2010).","journal-title":"BMC Bioinform."},{"key":"60293_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/omi.2021.0051","volume":"25","author":"SK Behera","year":"2021","unstructured":"Behera, S. K. et al. MS2Compound: a user-friendly compound identification tool for LC-MS\/MS-based metabolomics data. OMICS 25, 389\u2013399 (2021).","journal-title":"OMICS"},{"key":"60293_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3\u201326 (2001).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"60293_CR28","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrd1032","volume":"2","author":"H van de Waterbeemd","year":"2003","unstructured":"van de Waterbeemd, H. & Gifford, E. ADMET in silico modelling: towards prediction paradise?. Nat. Rev. Drug Discov. 2, 192\u2013204 (2003).","journal-title":"Nat. Rev. Drug Discov."},{"key":"60293_CR29","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1021\/jm015507e","volume":"44","author":"I Muegge","year":"2001","unstructured":"Muegge, I., Heald, S. L. & Brittelli, D. Simple selection criteria for drug-like chemical matter. J. Med. Chem. 44, 1841\u20131846 (2001).","journal-title":"J. Med. Chem."},{"key":"60293_CR30","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1021\/jm000292e","volume":"43","author":"WJ Egan","year":"2000","unstructured":"Egan, W. J., Merz, K. M. & Baldwin, J. J. Prediction of drug absorption using multivariate statistics. J. Med. Chem. 43, 3867\u20133877 (2000).","journal-title":"J. Med. Chem."},{"key":"60293_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/cc9800071","volume":"1","author":"AK Ghose","year":"1999","unstructured":"Ghose, A. K., Viswanadhan, V. N. & Wendoloski, J. J. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. J. Comb. Chem. 1, 55\u201368 (1999).","journal-title":"J. Comb. Chem."},{"key":"60293_CR32","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber, D. F. et al. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45, 2615\u20132623 (2002).","journal-title":"J. Med. Chem."},{"key":"60293_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"issue":"sp2","key":"60293_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.14719\/pst.1705","volume":"9","author":"S Dutta","year":"2022","unstructured":"Dutta, S., Prashanth, K. H. P., Ramesh, N. & Middha, S. K. Systematic analysis of Quercetin and its derivatives with special reference to anti-inflammatory property-based on network pharmacology. Plant Sci. Today 9(sp2), 41\u201346 (2022).","journal-title":"Plant Sci. Today"},{"key":"60293_CR35","doi-asserted-by":"publisher","first-page":"D684","DOI":"10.1093\/nar\/gkm795","volume":"36","author":"M Kuhn","year":"2007","unstructured":"Kuhn, M. et al. STITCH: Interaction networks of chemicals and proteins. Nucleic Acids Res. 36, D684 (2007).","journal-title":"Nucleic Acids Res."},{"key":"60293_CR36","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses. Nucleic Acids Res. 51, D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"key":"60293_CR37","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"60293_CR38","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin, C. H. et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8, S11 (2014).","journal-title":"BMC Syst. Biol."},{"key":"60293_CR39","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge, S. X., Jung, D. & Yao, R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36, 2628\u20132629 (2020).","journal-title":"Bioinformatics"},{"issue":"D1","key":"60293_CR40","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"Minoru Kanehisa","year":"2025","unstructured":"Kanehisa, Minoru et al. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53(D1), D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"60293_CR41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.52586\/4957","volume":"26","author":"T Usha","year":"2021","unstructured":"Usha, T. et al. Gas chromatography-mass spectrometry metabolic profiling and molecular simulation of phytochemicals of Punica granatum. Front. Biosci. 26, 423\u2013441 (2021).","journal-title":"Front. Biosci."},{"key":"60293_CR42","unstructured":"Hemavathi, K. N. et al. Computational screening of phytocompounds from C. amboinicus identifies inhibitors of influenza A virus. J. Biomol. Struct. Dyn. (2024)."},{"key":"60293_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108164","volume":"171","author":"KN Hemavathi","year":"2024","unstructured":"Hemavathi, K. N. et al. Computational screening of anti-inflammatory leads targeting COX-2 and 5-LOX. Comput. Biol. Med. 171, 108164 (2024).","journal-title":"Comput. Biol. Med."},{"key":"60293_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/1479-5876-11-241","volume":"11","author":"J Li","year":"2013","unstructured":"Li, J. et al. The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer. J. Transl. Med. 11, 241 (2013).","journal-title":"J. Transl. Med."},{"key":"60293_CR45","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1158\/1535-7163.MCT-11-0824-T","volume":"11","author":"BR Davies","year":"2012","unstructured":"Davies, B. R. et al. Preclinical pharmacology of AZD5363, an inhibitor of AKT. Mol. Cancer Ther. 11, 873\u2013887 (2012).","journal-title":"Mol. Cancer Ther."},{"key":"60293_CR46","doi-asserted-by":"publisher","first-page":"16384","DOI":"10.1021\/acsomega.4c00079","volume":"9","author":"N Lohitha","year":"2024","unstructured":"Lohitha, N. et al. Synthesis and DFT studies of phenylhydrazono phenoxyquinolones. ACS Omega 9, 16384\u201316399 (2024).","journal-title":"ACS Omega"},{"key":"60293_CR47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13058-023-01639-y","volume":"25","author":"XE Hu","year":"2023","unstructured":"Hu, X. E. et al. Clinical and biological heterogeneities in triple-negative breast cancer. Breast Cancer Res. 25, 34 (2023).","journal-title":"Breast Cancer Res."},{"key":"60293_CR48","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1089\/jicm.2022.0754","volume":"29","author":"VS Rao","year":"2023","unstructured":"Rao, V. S. et al. A scoping review of ayurveda studies in women with PCOS. J. Integr. Complement. Med. 29, 550\u2013561 (2023).","journal-title":"J. Integr. Complement. Med."},{"key":"60293_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaim.2024.101000","volume":"15","author":"PK Yadav","year":"2024","unstructured":"Yadav, P. K. et al. Ayurvedic management of hydatid cyst of lungs: a case report. J. Ayurveda Integr. Med. 15, 101000 (2024).","journal-title":"J. Ayurveda Integr. Med."},{"key":"60293_CR50","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen, Z. et al. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct. Target Ther. 8, 70 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"60293_CR51","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.semcancer.2017.07.001","volume":"49","author":"S Ahmad","year":"2018","unstructured":"Ahmad, S. et al. AGEs, RAGEs and s-RAGE: Friend or foe for cancer. Semin. Cancer Biol. 49, 44\u201355 (2018).","journal-title":"Semin. Cancer Biol."},{"key":"60293_CR52","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s11010-020-03928-y","volume":"476","author":"BN Waghela","year":"2021","unstructured":"Waghela, B. N. et al. AGE-RAGE synergy influences programmed cell death signaling to promote cancer. Mol. Cell. Biochem. 476, 585\u2013598 (2021).","journal-title":"Mol. Cell. Biochem."},{"key":"60293_CR53","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12079-020-00592-1","volume":"15","author":"MA Najar","year":"2021","unstructured":"Najar, M. A. et al. A complete map of the CAMKK2 signaling pathway. J. Cell Commun. Signal. 15, 283\u2013290 (2021).","journal-title":"J. Cell Commun. Signal."},{"key":"60293_CR54","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/j.bbamcr.2018.05.015","volume":"1865","author":"AH Bong","year":"2018","unstructured":"Bong, A. H. & Monteith, G. R. Calcium signaling and therapeutic targeting of cancer cells. Biochim. Biophys. Acta 1865, 1786\u20131794 (2018).","journal-title":"Biochim. Biophys. Acta"},{"key":"60293_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.597608","volume":"8","author":"M Sneeggen","year":"2020","unstructured":"Sneeggen, M., Guadagno, N. A. & Progida, C. Intracellular transport in cancer metabolic reprogramming. Front. Cell Dev. Biol. 8, 597608 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"60293_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-10920-8","volume":"10","author":"C Lin","year":"2019","unstructured":"Lin, C. et al. Membrane protein-regulated networks across human cancers. Nat. Commun. 10, 1\u201317 (2019).","journal-title":"Nat. Commun."},{"key":"60293_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104270","volume":"145","author":"A Alwhaibi","year":"2019","unstructured":"Alwhaibi, A., Verma, A., Adil, M. S. & Somanath, P. R. The unconventional role of Akt1 in advanced cancers. Pharmacol. Res. 145, 104270 (2019).","journal-title":"Pharmacol. Res."},{"key":"60293_CR58","doi-asserted-by":"publisher","first-page":"7947","DOI":"10.1038\/s41598-023-35122-7","volume":"13","author":"K Baby","year":"2023","unstructured":"Baby, K. et al. Computational drug repurposing of Akt-1 inhibitors for lung cancer. Sci. Rep. 13, 7947 (2023).","journal-title":"Sci. Rep."},{"key":"60293_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-022-00860-9","author":"P Tsai","year":"2022","unstructured":"Tsai, P. et al. Akt: A key transducer in cancer. J. Biomed. Sci. https:\/\/doi.org\/10.1186\/s12929-022-00860-9 (2022).","journal-title":"J. Biomed. Sci."},{"key":"60293_CR60","first-page":"95","volume":"32","author":"AK Ferreira","year":"2012","unstructured":"Ferreira, A. K. et al. Anticancer effects of synthetic phosphoethanolamine. Anticancer Res. 32, 95\u2013104 (2012).","journal-title":"Anticancer Res."},{"key":"60293_CR61","doi-asserted-by":"publisher","first-page":"1224125","DOI":"10.3389\/fonc.2023.1224125","volume":"13","author":"X Wang","year":"2023","unstructured":"Wang, X., Zhang, C. & Bao, N. Molecular mechanism of palmitic acid in tumor progression. Front. Oncol. 13, 1224125 (2023).","journal-title":"Front. Oncol."},{"key":"60293_CR62","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3390\/molecules30051018","volume":"30","author":"A Markowska","year":"2025","unstructured":"Markowska, A. et al. The role of ferulic acid in malignant neoplasms. Molecules 30, 1018 (2025).","journal-title":"Molecules"},{"key":"60293_CR63","first-page":"1915","volume":"57","author":"I Ahmad","year":"1997","unstructured":"Ahmad, I. et al. Enhanced therapeutic effects of liposome-associated phosphocholine. Cancer Res. 57, 1915\u20131921 (1997).","journal-title":"Cancer Res."},{"key":"60293_CR64","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1128\/AAC.45.5.1505-1510.2001","volume":"45","author":"K Seifert","year":"2001","unstructured":"Seifert, K. et al. Effects of miltefosine on Entamoeba histolytica. Antimicrob. Agents Chemother. 45, 1505\u20131510 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"60293_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.70467","volume":"13","author":"J Zhang","year":"2025","unstructured":"Zhang, J. et al. Di-p-coumaroyl spermidine from bee pollen alleviates prostatitis. Food Sci. Nutr. 13, e70467 (2025).","journal-title":"Food Sci. Nutr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60293-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60293-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60293-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:02:30Z","timestamp":1790902950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60293-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60293"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60293-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30625"}}